Literature DB >> 13680563

The role of capsular distention in adhesive capsulitis.

Vijay B Vad1, Durgadas Sakalkale, Russell F Warren.   

Abstract

OBJECTIVE: To explore the efficacy of capsular distension in the treatment of adhesive capsulitis of the shoulder joint.
DESIGN: Prospective study.
SETTING: Musculoskeletal clinic. PARTICIPANTS: Twenty-two patients (18 women, 4 men; mean age, 41.3y; range, 29-54y) with adhesive capsulitis of shoulder joint. Nineteen patients had Hannafin stage II and 3 patients had Hannafin stage III adhesive capsulitis. All patients had continuous pain and significant range of motion (ROM) limitations of the shoulder joint despite a minimum of 3 months of physical therapy (PT). INTERVENTION: Capsular distension with saline under fluoroscopic control, followed by a PT program. MAIN OUTCOME MEASURES: L'Insalata Shoulder Rating Questionnaire (LSRQ) score and Hannafin ROM assessment protocol.
RESULTS: In the 19 patients with stage II adhesive capsulitis, the mean LSRQ score and range of abduction improved from predistention values of 49.8 degrees and 87.2 degrees to postdistension mean values of 88.1 degrees and 117.6 degrees at minimum of 1 year postdistention, respectively (P<.05). However, in the 3 patients with stage III adhesive capsulitis, the mean LSRQ score and range of abduction changed from predistention values of 41.2 degrees and 84.1 degrees to postdistension mean values of 57.8 degrees and 90.4 degrees at minimum of 1 year postdistention, respectively (P>.05).
CONCLUSIONS: The treatment modality should be individualized on the basis of the stage of the adhesive capsulitis, and the distension procedure should be reserved for patients in stage II who do not progress despite participating in a PT program.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 13680563     DOI: 10.1016/s0003-9993(03)00261-2

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  7 in total

1.  Randomized controlled trial for efficacy of capsular distension for adhesive capsulitis: fluoroscopy-guided anterior versus ultrasonography-guided posterolateral approach.

Authors:  Jae Hyun Bae; Young Sook Park; Hyun Jung Chang; Min Jung Kim; Kang Young Park; Seung Hwan Jin; Eun Hee Lee
Journal:  Ann Rehabil Med       Date:  2014-06-26

2.  Hydrodilatation (distension arthrography): a long-term clinical outcome series.

Authors:  Lyn Watson; Andrea Bialocerkowski; Rodney Dalziel; Simon Balster; Frank Burke; Caroline Finch
Journal:  Br J Sports Med       Date:  2006-12-18       Impact factor: 13.800

3.  Comparison of Sono-guided Capsular Distension with Fluoroscopically Capsular Distension in Adhesive Capsulitis of Shoulder.

Authors:  Ki Deok Park; Hee Seung Nam; Tai Kon Kim; Seong Hoon Kang; Min Ho Lim; Yongbum Park
Journal:  Ann Rehabil Med       Date:  2012-02-29

4.  Effectiveness of Glenohumeral Joint Dilatation for Treatment of Frozen Shoulder: A Systematic Review and Meta-analysis of Randomized Controlled Trials.

Authors:  Wei-Ting Wu; Ke-Vin Chang; Der-Sheng Han; Chung-Hsun Chang; Fu-Sui Yang; Chih-Peng Lin
Journal:  Sci Rep       Date:  2017-09-05       Impact factor: 4.379

5.  Interventional microadhesiolysis: a new nonsurgical release technique for adhesive capsulitis of the shoulder.

Authors:  Kang Ahn; Young-Jin Lee; Eun-Ha Kim; Seung-Min Yang; Tae-Kyun Lim; Yong-Soo Kim; Hyung-Joon Jhun
Journal:  BMC Musculoskelet Disord       Date:  2008-01-29       Impact factor: 2.362

6.  Correlations between MRI findings and outcome of capsular distension in adhesive capsulitis of the shoulder.

Authors:  Yun Hee Park; Young Sook Park; Hyun Jung Chang; Yeongmi Kim
Journal:  J Phys Ther Sci       Date:  2016-10-28

7.  Clostridium histolyticum (AA4500) for the Treatment of Adhesive Capsulitis of the Shoulder: A Randomised Double-Blind, Placebo-Controlled Study for the Safety and Efficacy of Collagenase - Single Site Report.

Authors:  Jane Fitzpatrick; Christen Richardson; Ianiv Klaber; Martin D Richardson
Journal:  Drug Des Devel Ther       Date:  2020-07-10       Impact factor: 4.162

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.